US Patent 10738126 Anti-GITR antibodies and uses thereof
Patent 10738126 was granted and assigned to Regeneron Pharmaceuticals on August, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 9, 2017
Date of Patent
August 11, 2020
Patent Applicant
Patent Application Number
15619068
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10738126 Anti-GITR antibodies and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
